Definium Therapeutics, Inc. · NASDAQ:DFTX
Commodore Capital LP reported a 7.20% stake in Definium Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Commodore Capital LP reported a 7.20% stake in Definium Therapeutics, Inc., 7,428,775 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 7.20%
- Shares
- 7,428,775
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 7.20% | 7,428,775 |
| Commodore Capital Master LP | 7.20% | 7,428,775 |
| Robert Egen Atkinson | 7.20% | 7,428,775 |
| Michael Kramarz | 7.20% | 7,428,775 |
Source
Related
- Definium Therapeutics, Inc.
- Commodore Capital LP
- Definium Therapeutics, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026